Neoadjuvant gemcitabine and docetaxel in primary breast angiosarcoma revealed complete pathological remission

1. Adem C, Reynolds C, Ingle JN, Nascimento AG. Primary breast sarcoma: clinicopathologic series from the Mayo Clinic and review of the literature. Br J Cancer. 2004; 91:237-41.10.1038/sj.bjc.6601920Search in Google Scholar

2. Moore MP, Kinne DW. Breast sarcoma. Surg Clin North Am. 1996; 76:383-92.10.1016/S0039-6109(05)70445-XOpen DOISearch in Google Scholar

3. Karlsson P, Holmberg E, Samuelsson A, Johansson KA, Wallgren A. Soft tissue sarcoma after treatment forSearch in Google Scholar

4. Scow JS, Reynolds CA, Degnim AC, Petersen IA, Jakub JW, Boughey JC. Primary and secondary angiosarcoma of the breast: the Mayo Clinic experience. J Surg Oncol. 2010; 101:401-7.10.1002/jso.2149720119983Search in Google Scholar

5. Monroe AT, Feigenberg SJ, Mendenhall NP. Angiosarcoma after breast-conserving therapy. Cancer. 2003; 97:1832-40.10.1002/cncr.1127712673708Open DOISearch in Google Scholar

6. Penel N, Bui BN, Bay JO, Cupissol D, Ray-Coquard I, Piperno-Neumann S, et al. Phase II trial of weekly paclitaxel for unresectable angiosarcoma: the ANGIOTAX Study. J Clin Oncol. 2008; 26:5269-74.10.1200/JCO.2008.17.314618809609Open DOISearch in Google Scholar

7. Italiano A, Cioffi A, Penel N, Levra MG, Delcambre C, Kalbacher E, et al. Comparison of doxorubicin and weekly paclitaxel efficacy in metastatic angiosarcomas. Cancer. 2012; 118:3330-6.10.1002/cncr.2659922045619Open DOISearch in Google Scholar

8. Sher T, Hennessy BT, Valero V, Broglio K, Woodward WA, Trent J, et al. Primary angiosarcomas of the breast. Cancer. 2007; 110:173-8.10.1002/cncr.22784432977917541936Search in Google Scholar

9. Nagano T, Yamada Y, Ikeda T, Kanki H, Kamo T, Nishigori C. Docetaxel: a therapeutic option in the treatment of cutaneous angiosarcoma: report of 9 patients. Cancer. 2007; 110:648-51.10.1002/cncr.2282217582627Search in Google Scholar

10. Marchant LK, Orel SG, Perez-Jaffe LA, Reynolds C, Schnall MD. Bilateral angiosarcoma of the breast on MR imaging. AJR Am J Roentgenol. 1997; 169: 1009-10.10.2214/ajr.169.4.93084529308452Search in Google Scholar

11. Fujita T, Taira N, Ogasawara Y, Omori M, Doihara H. Bilateral angiosarcoma of the breast detected by magnetic resonance imaging during pregnancy. Int J Clin Oncol. 2009; 14:560-3.10.1007/s10147-009-0895-219967497Open DOISearch in Google Scholar

12. Boonjunwetwat D. Textbook of Breast Imaging. 1 ed: Chulalongkorn; 2011.Search in Google Scholar

13. Salas S, Bui B, Stoeckle E, Terrier P, Ranchere-Vince D, Collin F, et al. Soft tissue sarcomas of the trunk wall (STS-TW): a study of 343 patients from the French Sarcoma Group (FSG) database. Ann Oncol. 2009; 20: 1127-35.10.1093/annonc/mdn75719179555Open DOISearch in Google Scholar

14. Yang WT, Hennessy BT, Dryden MJ, Valero V, Hunt KK, Krishnamurthy S. Mammary angiosarcomas: imaging findings in 24 patients. Radiology. 2007; 242: 725-34.10.1148/radiol.242306016317325063Search in Google Scholar

15. Bae SY, Choi MY, Cho DH, Lee JE, Nam SJ, Yang JH. Large clinical experience of primary angiosarcoma of the breast in a single Korean medical institute. World J Surg. 2011; 35:2417-21.10.1007/s00268-011-1225-121882024Open DOISearch in Google Scholar

16. Liberman L, Dershaw DD, Kaufman RJ, Rosen PP. Angiosarcoma of the breast. Radiology. 1992; 183: 649-54.10.1148/radiology.183.3.15849131584913Search in Google Scholar

17. Kim YJ LK, Cho YU. MR imaging and spectroscopic finding of primary angiosarcoma of the breast: a case report. J korean Radiol Soc 2006; 54:557-60.10.3348/jkrs.2006.54.6.557Search in Google Scholar

18. Stacchiotti S, Palassini E, Sanfilippo R, Vincenzi B, Arena MG, Bochicchio AM, et al. Gemcitabine in advanced angiosarcoma: a retrospective case series analysis from the Italian Rare Cancer Network. Ann Oncol. 2012; 23:501-8.10.1093/annonc/mdr06621464156Open DOISearch in Google Scholar

19. Hensley ML, Blessing JA, Mannel R, Rose PG. Fixeddose rate gemcitabine plus docetaxel as first-line therapy for metastatic uterine leiomyosarcoma: a Gynecologic Oncology Group phase II trial. Gynecol Oncol. 2008; 109:329-34.10.1016/j.ygyno.2008.03.010250472718534250Search in Google Scholar

20. Maki RG, Wathen JK, Patel SR, Priebat DA, Okuno SH, Samuels B, et al. Randomized phase II study of gemcitabine and docetaxel compared with gemcitabine alone in patients with metastatic soft tissue sarcomas: results of sarcoma alliance for research through collaboration study 002 [corrected]. J Clin Oncol. 2007; 25:2755-63.10.1200/JCO.2006.10.411717602081Open DOISearch in Google Scholar

21. Leu KM, Ostruszka LJ, Shewach D, Zalupski M, Sondak V, Biermann JS, et al. Laboratory and clinical evidence of synergistic cytotoxicity of sequential treatment with gemcitabine followed by docetaxel in the treatment of sarcoma. J Clin Oncol. 2004; 22: 1706-12.10.1200/JCO.2004.08.04315117993Open DOISearch in Google Scholar

22. Shkoukani MA, Carron MA, Tulunay O, Kucuk O, Lin HS. Angiosarcoma of the scalp with complete response to a biweekly gemcitabine and docetaxel (GEMDOC) chemotherapy regimen. Ear Nose Throat J. 2011; 90:E26-9.10.1177/01455613110900011821229496Search in Google Scholar

23. Wilson R, Glaros S, Brown RK, Michael C, Reisman D. Complete radiographic response of primary pulmonary angiosarcomas following gemcitabine and taxotere. Lung Cancer. 2008; 61:131-6.10.1016/j.lungcan.2007.12.00618243404Open DOISearch in Google Scholar